Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies

NCT02128945 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT02128945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02128945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies
Lead sponsor
University Hospital, Caen
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
May 31, 2016
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

untreated b-chronic lymphocytic leukemia or diffuse large b cells lymphoma patients